Health
Moderna runs trials on new booster shots against COVID-19 variants – New York Post
The first participants in Moderna’s trial assessing new variant-specific booster shots have been vaccinated, the company announced. The new vaccines target a coronavirus…
The first participants in Modernas trial assessing new variant-specific booster shots have been vaccinated, the company announced. The new vaccines target a coronavirus variant first detected in South Africa, which has demonstrated reduced vaccine efficacy.
Moderna is testing three variations of a booster among 60 vaccinated participants. First, it will study the variant-specific jab, which will be given at a lower dose than its original vaccine (20 micrograms), and will require an evaluation and…
Continue Reading
